Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database
Source: docwirenews, June 2021
This study investigated the impact of treating facility type on guideline-concordant sentinel lymph node biopsy (SLNB) management in T1a* (defined as a Breslow depth <0.76 mm without ulceration or mitoses) and T2/T3 melanoma.
METHODS: This was a retrospective cohort study utilizing the National Cancer Database from 2012 to 2016.
